Corrigendum: A combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy in vivo
Main Authors: | Shreyas S. Kuduvalli, Precilla S. Daisy, Anandraj Vaithy, Mugilarasi Purushothaman, Arumugam Ramachandran Muralidharan, Kumar B. Agiesh, Markus Mezger, Justin S. Antony, Madhu Subramani, Biswajit Dubashi, Indrani Biswas, K. P. Guruprasad, T. S. Anitha |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-01-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1322332/full |
Similar Items
-
A combination of metformin and epigallocatechin gallate potentiates glioma chemotherapy in vivo
by: Shreyas S. Kuduvalli, et al.
Published: (2023-03-01) -
Antioxidant and antiviral activities of lipophilic epigallocatechin gallate (EGCG) derivatives
by: Ying Zhong, et al.
Published: (2012-01-01) -
Protective Effect of Liposomal Epigallocatechin-Gallate in Experimental Gentamicin-Induced Hepatotoxicity
by: Adriana Elena Bulboacă, et al.
Published: (2022-02-01) -
Synthesis and Biological Testing of Novel Glucosylated Epigallocatechin Gallate (EGCG) Derivatives
by: Xin Zhang, et al.
Published: (2016-05-01) -
Y6, an Epigallocatechin Gallate Derivative, Reverses ABCG2-Mediated Mitoxantrone Resistance
by: Rui-Qiang Zhao, et al.
Published: (2019-01-01)